Ronacue Tablet 8 mg (Blonanserin)

Adult dose

Adults: Administer 4mg orally twice daily after meals, increasing the dose gradually. The maintenance dose is 8∼16mg per day, divided into 2 doses after meals. Since the absorption of this medicine is readily affected by food, it must be taken after meals. Carefully monitor each patient and adjust the dose to the minimum required. Do not exceed the maximum daily dose of 24mg.

This medication may increase the risk of death in elderly dementia patients, so caution is required. The risk of cerebrovascular disease may be higher in dementia patients, so it is especially important to be careful if there are risk factors for stroke. There is a risk of venous thrombosis during the use of this medication, so it is necessary to check for risk factors for thrombosis and take preventive measures. It should not be used in patients who are comatose or who are taking central nervous system depressants. Serious interactions may occur when used in conjunction with adrenaline or certain antifungals and HIV protease inhibitors, so these combinations should be avoided. Patients with allergies to the components of this medication or those with lactose intolerance should also avoid using it. Patients with cardiovascular diseases, Parkinson's disease, seizure disorders, a risk of suicide, liver dysfunction, and diabetes should be administered cautiously and monitored closely. Pregnant or breastfeeding women should avoid use or make careful judgments as it may affect the fetus or newborn. This medication can cause drowsiness and reduced attention, so caution is needed when driving or operating dangerous machinery. Blood sugar may be increased, so diabetic patients should periodically check their blood sugar levels. If any abnormal symptoms occur during use, consult a doctor immediately, and this medication should be taken after meals for stable effects. Additionally, since this medication is metabolized in the liver, caution is required as drug concentrations may increase in patients with impaired liver function or when used with drugs that inhibit CYP3A4 enzyme activity. Elderly patients are at higher risk for side effects, so they should be administered cautiously and monitored frequently. Safety in children and neonates has not been established, so usage is not recommended.

Tremors, bradykinesia, excessive salivation, Parkinson's syndrome, akathisia, insomnia, elevated prolactin, movement disorders, drowsiness, anxiety, restlessness, irritability, neuroleptic malignant syndrome, akinetic mutism, muscle rigidity, dysphagia, tachycardia, blood pressure fluctuations, sweating, altered consciousness, dyspnea, circulatory collapse, dehydration, acute kidney injury, tardive dyskinesia, involuntary orofacial muscle movements, paralytic ileus, decreased appetite, nausea, vomiting, diarrhea, abdominal distension, lethargy, antidiuretic hormone secretion disorder syndrome, hyponatremia, hypotonicity, urinary sodium hyperexcretion, high urine output, convulsions, rhabdomyolysis, myalgia, feeling weak, elevated CK, elevated myoglobin in the blood, elevated myoglobin in the urine, agranulocytosis, leukopenia, liver dysfunction, elevated AST, elevated ALT, elevated γ-GTP, elevated ALP, elevated bilirubin, hyperglycemia, diabetic ketoacidosis, diabetic coma, eosinophilia, drug reactions with systemic symptoms, rash, eczema, pruritus, hypotension, orthostatic hypotension, hypertension, electrocardiogram abnormalities, tachycardia, bradycardia, arrhythmia, ventricular extrasystole, loss-of-control extrasystole, palpitations, decreased heart rate, symptoms of Parkinson’s disease, akathisia, dyskinesia, abnormal muscle tone, facial spasms, pharyngeal spasms, uterine spasms, ocular motor seizures, camptocormia, control disorders, blurred vision, constipation, decreased appetite, increased appetite, diarrhea, upper abdominal pain, abdominal pain, gastrointestinal disorders, cheilitis, menstrual irregularities, galactorrhea, ejaculation disorders, gynecomastia, erectile dysfunction, dysuria, urinary retention, urinary incontinence, frequent urination, dizziness, vertigo, dull headache, headache, agitation, hyper-sedation, over-inhibition, depression, hallucinations, auditory hallucinations, delusions, persecutory delusions, sleep disorders, abnormal behavior, hyperactivity, abnormal EEG, manic state, altered consciousness, emotional disturbances, speech disorders, talkativeness, tension, convulsions, leukocytosis, neutrophilia, lymphocytopenia, erythrocytosis, anemia, erythropenia, reduced hemoglobin, reduced hematocrit, thrombocytosis, thrombocytopenia, atypical lymphocytes, generalized malaise, thirst, feeling weak, sweating, fever, weight gain, weight loss, chest pain, cough, facial edema, aspiration pneumonia, hypothermia, elevated CK, increased triglycerides, elevated cholesterol in the blood, increased insulin in the blood, increased phospholipids in the blood, elevated blood sugar, increased BUN, decreased total protein in the blood, increased potassium in the blood, decreased potassium in the blood, decreased sodium in the blood, positive urine protein, positive urine urobilin, positive urine glucose, epidermolytic necrosis, lethargy, thromboembolism, pulmonary embolism, deep vein thrombosis

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication over time.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle